期刊文献+

胸腺切除治疗重症肌无力围手术期处理 被引量:1

PERIOPERATIVE MANAGEMENT OF THYMECTOMY FOR MYASTHENIA GRAVIS
下载PDF
导出
摘要 目的 :对胸腺切除术治疗的重症肌无力 (myastheniagravis ,MG)病人进行围手术期处理 ,评价其疗效。方法 :5 4例重症肌无力病人 ,手术前处理合并症、口服皮质类固醇、胆碱酯酶抑制剂改善肌无力 ,术中彻底清扫胸腺及前纵隔脂肪 ,术后防治危象。结果 :所有病人均安全渡过围手术期 ,无住院死亡。结论 :重症肌无力病人 ,只要围手术期处理恰当 ,均可安全接受胸腺手术治疗。 Objective:To assess the effects of perioperative management of thymectomy for myasthenia gravis(MG).Methods:Fifty-four cases of MG were treated on basis of the perioperative management of thymectomy.Patients took orally corticosteroids and cholinesterase inhibitor.The sternum was split,after which an en bloc dissection of anterior mediastinal fat tissues,including the thymus,was performed.Results:All patients safely survived the perioperative phase,and no patient died in hospital.Conclusion:Thymectomy could be performed in all the MG patients who received the perioperative treatment.
出处 《内蒙古医学院学报》 2001年第4期230-233,共4页 Acta Academiae Medicinae Neimongol
关键词 重症肌无力 胸腺切除术 围手术期处理 myasthenia gravis thymectomy perioperative management
  • 相关文献

参考文献5

  • 1Nieto IP, Roblel JPP, Pajulo MC, et al. Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases [J]. Ann Thorac Surg, 1999; 67:1568 ~ 1571
  • 2李泽坚.胸腺与重症肌无力.见孙衍庆主编.现代胸心外科学[M].北京:人民军医出版社,2000;733~746
  • 3费立夫 李翠艳 等.8例重症肌无力合并甲状腺功能亢进外科治疗体会[J].中华胸心血管外科杂志,2000,16(1):8-8.
  • 4Masaoka A, Yamakawa Y, Niwa H, et al. Thymectomy for myasthenia gravis patients:a 20 - year review[J ]. Ann Thorac Surg , 1996; 62: 853~ 859
  • 5张其刚,胡永校,李玉,张林,殷洪年,李建华.61例重症肌无力病人前纵隔内异位胸腺分布规律[J].中华胸心血管外科杂志,1999,15(1):39-39. 被引量:18

二级参考文献3

共引文献24

同被引文献18

  • 1杨明山,卜碧涛.重症肌无力的治疗进展[J].神经损伤与功能重建,2007,2(2):69-74. 被引量:21
  • 2周水珍.重症肌无力的诊断与治疗现状[J].中国实用儿科杂志,2007,22(7):486-489. 被引量:15
  • 3Katirji B, Kaminski HJ. Electrodiagnostic approach to the patient with suspected neuromuscular junction disorder [ J ]. Neurol Clin ,2002 ;20 ( 2 ) :557 - 586.
  • 4Keesey JC. Clinical evaluation and management of myasthenia gravis[ J]. Muscle Nerve,2004 ;29(4) :484 -505.
  • 5Vincent A, McConville J, Farrugia ME, et al. Seronegatire myasthenia gravis [ J ]. Semin Neurol , 2004 ; 24 ( 1 ): 125 - 133.
  • 6Bedlack RS, Sanders DB. Steroid treatment for myasthenia gravis : steroids have an important role [J]. Muscle Nerve, 2002 ;25( 1 ) : 117 - 121.
  • 7Spring PJ, Spies JM. Myasthenia gravis:options and timing of immunomodulatory treatment [ J ]. BioDrugs ,2001 ;15 (3) :173 - 183.
  • 8Lindner A, Schalke B, Toyka KV. Outcome in juvenile - onset myasthenia gravis: a retrospective study with long - term follow - up of 79 patients[ J]. J Neurol, 1997 ;244 (8) :515 -520.
  • 9Palace J, Newsom - Davis J, Lecky B. A randomized double - blind trial of prednisolone alone or with azathioprine in myasthenia gravis [ J ]. Neurology, 1998 ; 50 ( 6 ) : 1778 - 1783.
  • 10Tindall RS, Rollins JA, Phillips JT, et al. Preliminary results of a double - blind, randomized, placebo - controlled trial of cyclosporine in myasthenia gravis [ J ]. N Engl J Med,1987 ;316(12) :719 -724.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部